| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/19/2009 | US20090048200 GPR 26 G-Protein Coupled Receptor |
| 02/19/2009 | US20090048199 Hibernation-Related Genes and Proteins, Activators and Inhibitors Thereof and Methods of Use |
| 02/19/2009 | US20090048196 Membrane receptor for retinol binding protein mediates cellular uptake of vitamin A, methods of use and compositions |
| 02/19/2009 | US20090048194 Vagal Afferent Neurons as Targets for Treatment |
| 02/19/2009 | US20090048176 Antibacterial agent |
| 02/19/2009 | US20090048169 Identification of Crmp4 as a Convergent Regulator of Axon Outgrowth Inhibition |
| 02/19/2009 | US20090048161 Cytokine receptor modulators and uses thereof |
| 02/19/2009 | US20090048146 Use of agents that upregulate crystallin expression in the retina and optic nerve head |
| 02/19/2009 | US20090048124 Methods of amplifying and sequencing nucleic acids |
| 02/19/2009 | US20090048121 Screening Method for the Early Diagnosis of Cerebral Vasospasm |
| 02/19/2009 | US20090048118 Oligonucleotides, Arrays Thereof for Detecting Microorganisms, and an Apparatus, a Method and a Kit for Detecting Microorganisms |
| 02/19/2009 | US20090048117 Modulation of immune system function by modulation of polypeptide arginine methyltransferases |
| 02/19/2009 | US20090048115 Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis |
| 02/19/2009 | US20090047744 Method for Improving the Characterisation of a Polynucleotide Sequence |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047736 Human T1R2 nucleic acid sequences and polypeptides |
| 02/19/2009 | US20090047703 ERG-1 Peptides and Polynucleotides and Their Use in the Treatment and Diagnosis of Disease |
| 02/19/2009 | US20090047702 Method for Identifying Modulators of Keah6 Useful for Treating Alzheimer's Disease |
| 02/19/2009 | US20090047701 Method for screening antifungal agents |
| 02/19/2009 | US20090047700 Flourescence Assay for MTP Activity |
| 02/19/2009 | US20090047699 Fluorogenic enzyme activity assay methods and compositions using fragmentable linkers |
| 02/19/2009 | US20090047698 Reaction medium for Vibrio bacteria |
| 02/19/2009 | US20090047697 Natriuretic peptides and placenta growth factor levels for risk stratification |
| 02/19/2009 | US20090047696 Detection of infectious prion protein by seeded conversion of recombinant prion protein |
| 02/19/2009 | US20090047695 Microdevices for high-throughput screening of biomolecules |
| 02/19/2009 | US20090047694 Clinical Intervention Directed Diagnostic Methods |
| 02/19/2009 | US20090047693 Luciferase Detection Assay System |
| 02/19/2009 | US20090047692 Optically-detectable enzyme substrates and their method of use |
| 02/19/2009 | US20090047688 Reagents, kits and methods for detecting biological molecules by energy transfer from an activated chemiluminescent substrate to an energy acceptor dye |
| 02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
| 02/19/2009 | US20090047684 Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan |
| 02/19/2009 | US20090047683 Have negatively charged substituent for fluorescent staining of DNA; used to distinguish DNA present in a sample from RNA |
| 02/19/2009 | US20090047682 Method of detecting and predicting bronchodilatory response to beta agonist |
| 02/19/2009 | US20090047681 Entropic trapping and sieving of molecules |
| 02/19/2009 | US20090047680 Methods and compositions for high-throughput bisulphite dna-sequencing and utilities |
| 02/19/2009 | US20090047679 Method and system for analyzing reactions using an information system |
| 02/19/2009 | US20090047678 Accelerated cascade amplification (aca) of nucleic acids comprising strand and sequence specific dna nicking |
| 02/19/2009 | US20090047677 Methods for generating a distribution of optimal solutions to nondeterministic polynomial optimization problems |
| 02/19/2009 | US20090047676 System and method for obtaining and maintaining high-resistance seals in patch clamp recordings |
| 02/19/2009 | US20090047675 Compositions and methods for indentifying transforming and tumor suppressor genes |
| 02/19/2009 | US20090047674 Method for nucleic acid isolation and amplification |
| 02/19/2009 | US20090047673 Miniaturized lateral flow device for rapid and sensitive detection of proteins or nucleic acids |
| 02/19/2009 | US20090047672 Telomerase RNA Subunit and Methods of Use Thereof |
| 02/19/2009 | US20090047671 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 02/19/2009 | US20090047670 nucleic acid molecule characterized by being able to self-anneal into a hairpin conformation, and hybridizes to a target nucleic acid that is unique to methicillin-resistant Staphylococcus spp; sensor chip that includes a fluorescence quenching surface and nucleic acid molecules |
| 02/19/2009 | US20090047669 DNA recombination junction detection |
| 02/19/2009 | US20090047668 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 02/19/2009 | US20090047667 Salivary transcriptome diagnostics |
| 02/19/2009 | US20090047666 Methods and nucleic acids for the analysis of colon proliferative disorders |
| 02/19/2009 | US20090047665 Compositions for use in identification of adenoviruses |
| 02/19/2009 | US20090047664 Species detection methods and systems |
| 02/19/2009 | US20090047663 Methods and Compositions For Identifying and Characterizing Hepatitis C |
| 02/19/2009 | US20090047662 for measuring the therapeutic efficacy of various HIV treatment regimes such as highly active antiretroviral therapy (HAART); Using CCR5 and CXCR4 coreceptor usage as diagnostic indicator of AIDS disease progression in patients; determining most effective antiviral treatments for AIDS patients |
| 02/19/2009 | US20090047661 Quantitative hiv phenotype or tropism assay |
| 02/19/2009 | US20090047660 Antibodies for oncogenic strains of HPV and methods of their use |
| 02/19/2009 | US20090047659 Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations |
| 02/19/2009 | US20090047658 Methods and compositions for determining the pathogenic status of infectious agents |
| 02/19/2009 | US20090047657 Detection Method For Latent Viral Infections and Its Kit For Examination |
| 02/19/2009 | US20090047656 Molecular analysis of primary cells |
| 02/19/2009 | US20090047655 Method Of Screening Candidate Drug |
| 02/19/2009 | US20090047440 Fluid delivery system |
| 02/19/2009 | US20090047381 Ammonia transporter gene and use thereof |
| 02/19/2009 | US20090047380 Catalase gene and use thereof |
| 02/19/2009 | US20090047300 Blood-brain barrier epitopes and uses thereof |
| 02/19/2009 | US20090047299 Modified alpha-galactosyl ceramides for staining and stimulating natural killer t cells |
| 02/19/2009 | US20090047287 Modulation of bone formation |
| 02/19/2009 | US20090047286 H2n3 influenza a viruses and methods of use |
| 02/19/2009 | US20090047283 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/19/2009 | US20090047282 Prophylactic/Therapeutic Agent for Cancer |
| 02/19/2009 | US20090047275 Modulating calvarial osteoblast differentiation; fracture repair |
| 02/19/2009 | US20090047274 Diagnostic and therapeutic target cdc2l6 proteins for neurodegenerative diseases |
| 02/19/2009 | US20090047259 Methods of Using the Calcineurin A Variant CnA-beta 1 |
| 02/19/2009 | US20090047254 Bacteriophage and their uses |
| 02/19/2009 | US20090047246 Novel inhibitors of hepatitis c virus replication |
| 02/19/2009 | US20090047245 Prognostic chronic hepatitis C biomarkers |
| 02/19/2009 | US20090047219 Visible to near-infrared light probe using energy transfer between luciferase and an organic dye via a sugar chain |
| 02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |
| 02/19/2009 | US20090047215 MN/CA IX and Breast Cancer Therapy |
| 02/19/2009 | US20090047214 Novel methylation marker |
| 02/19/2009 | US20090045327 Aerial-supported procedure for exploration of hydrocarbon deposits |
| 02/19/2009 | US20090045055 Sensor head for use with implantable devices |
| 02/19/2009 | DE102007037008A1 Diagnosesubstanz zur Anwendung in einem Verfahren zur Bestimmung der Aggressivität eines Prostatatumors und Diagnoseverfahren Diagnostic substances for use in a method for determining the aggressiveness of a prostate tumor and diagnostic methods |
| 02/19/2009 | DE102007036570A1 Screeningtest zur Erkennung von Prostataerkrankungen sowie Vorrichtung und Diagnosesubstanz zur Durchführung des Tests Screening test for the detection of prostate disease as well as apparatus and diagnostic substance for carrying out the test |
| 02/19/2009 | CA2733676A1 Microrna compositions and methods for the treatment of myelogenous leukemia |
| 02/19/2009 | CA2696843A1 Method, system and software arrangement for comparative analysis and phylogeny with whole-genome optical maps |
| 02/19/2009 | CA2696372A1 Polymer microfluidic biochip fabrication |
| 02/19/2009 | CA2696250A1 Barley with low levels of hordeins |
| 02/19/2009 | CA2696047A1 A method for identifying, expanding, and removing adult stem cells and cancer stem cells |
| 02/19/2009 | CA2695972A1 Ivig modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's disease |
| 02/19/2009 | CA2695969A1 Regulators of mmp-9 and uses therof |
| 02/19/2009 | CA2695485A1 Predictive markers for egfr inhibitor treatment |
| 02/19/2009 | CA2695473A1 Predictive marker for egfr inhibitor treatment |
| 02/19/2009 | CA2695471A1 Predictive marker for egfr inhibitor treatment |
| 02/19/2009 | CA2695415A1 Egfr inhibitor treatment marker |
| 02/19/2009 | CA2695414A1 Method for estimating telomere length |
| 02/19/2009 | CA2695318A1 Predictive marker for egfr inhibitor treatment |
| 02/19/2009 | CA2695250A1 Predictive marker for egfr inhibitor treatment |
| 02/19/2009 | CA2695247A1 Predictive marker for egfr inhibitor treatment |
| 02/19/2009 | CA2695070A1 Predictive marker for egfr inhibitor treatment |
| 02/19/2009 | CA2695064A1 Predictive markers for egfr inhibitors treatment |